Singapore legislation
Schedule 20
Schedule 20
Form of product highlights sheet for asset‑backed securities or structured notes
TWENTIETH SCHEDULERegulation 7(1)(a)(i), (4), (5) and (6)Form of product highlights sheet for asset‑backed securities or structured notesPart 1Prepared on: DD/MM/YYYYThis Product Highlights Sheet is an important document.•It highlights the key terms and risks of this investment product and complements the Prospectus1.•It is important to read the Prospectus before deciding whether to purchase the product. If you do not have a copy, please contact us to ask for one.•You should not invest in the product if you do not understand it or are not comfortable with the accompanying risks.•If you wish to purchase the product, you will need to make an application in the manner set out in the Prospectus.___________________________________1 The Prospectus comprises the Base Prospectus and the Pricing Statement registered by the MAS on DD/MM/YYYY and DD/MM/YYYY respectively. It is available for collection at [time and place] or accessible at [website address, if applicable].NAME OF PRODUCTProduct type[Structured Note / Asset‑backed Security]Issue Date[●]Issue Price[●]Maturity Date[●]Maximum loss[●] [in % term]Offer Period[●]Maximum gain[●] [in % term]Callable by issuer[Yes/No]Name of issuer[●]Capital Guaranteed[Yes/No]Buyback FrequencyEvery Business Day / Every Monday etc.Name of Guarantor (if applicable)[●] WHO IS THE PRODUCT SUITABLE FOR? ●This product is only suitable for investors who:○[State return objectives (for example, capital growth, income or capital preservation) which the product will be suitable for.]○[State if the principal will be at risk.]○[State how long investors should be prepared to hold the investment for, and highlight any lock‑in periods or issuer‑callable features.]○[State other key characteristics of the product which will help investors determine whether the product is suitable for them.]Further InformationRefer to the “[Relevant Section]” of the Prospectus for further information on product suitability. Example:●The Notes are only suitable for investors who:○want regular income rather than capital growth;○are prepared to lose their principal investment if the issuer fails to repay the amount due under the Notes; and○are prepared to hold their investment for the full X years. However, after Y years the product may be callable by the issuer. WHAT ARE YOU INVESTING IN? [State key features of the product, such as the legal classification of the product, payoff and factors determining the payoff, underlying securities and whether and how they would affect the payoff, or whether there is any capital guarantee. Where appropriate, include one or more diagrams or illustrations explaining the features and structure of the product.]Refer to the “[Relevant Section]” of the Prospectus for further information on features of the product, including how the redemption amount is calculated. Example:●You are investing in a X‑year equity‑linked structured note in which you may receive quarterly coupons between W% and Y% per annum issued by [name of issuer of the Notes]. ●During the term of the investment, the issuer agrees to pay you quarterly coupons which depend on the share price performance of:○Company A○Company B○Company C. ●The amount of coupons is calculated as follows:○[Formula for calculation of coupons]. ●At maturity, the issuer agrees to pay you 100% of your principal investment, unless [list circumstances where investor may not receive 100% of principal investment]. ●The product is secured by [type of underlying securities] issued by [name of issuer of underlying securities]. [State all parties involved in the structure of the product, such as issuer, arranger, derivative counterparty, derivative guarantors, issuer of underlying securities, trustee and custodian.]WHO ARE YOU INVESTING WITH?●The Notes are issued by [name of issuer of the Notes] and arranged by [name of arranger of the Notes]. [Name of derivative counterparty] is the swap counterparty of the Notes. [Name of issuer of underlying securities] is the issuer of the underlying securities of the Notes.Refer to the “[Relevant Section]” of the Prospectus for further information on the role and responsibilities of these entities and what happens if they become insolvent.●The trustee of the Notes is [Name of trustee]. WHAT WOULD YOU GAIN OR LOSE IN DIFFERENT SITUATIONS? ●Best case scenario:○[Describe payoff to investor in best case scenario and factors that could lead to this scenario.] ●Worst case scenario:○[Describe payoff to investor in worst case scenario and factors that could lead to this scenario.] ●Other possible scenarios:○[Describe payoff to investor in other possible scenarios and factors that could lead to this scenario. Include scenario where issuer calls the debenture if applicable.] WHAT ARE THE KEY RISKS OF THIS INVESTMENT? [State key risks which are either commonly occurring events, or which may cause significant losses if they occur, or both. While the risks may overlap into multiple categories below, there is no need to repeat the same risk in more than one section. Product‑specific market or liquidity risks should be included under the market or liquidity risks section respectively. Where there is a risk that an investor may lose all of his initial principal investment, emphasise this with bold or italicised formatting.]Refer to the “[Relevant Section]” of the Prospectus for further information on risks.These risk factors may cause you to lose some or all of your investment: [State market risks (including currency risks) and counterparty risks which may result in the loss of capital or affect the payoff of the investment and their consequences.] Example:●You are exposed to the credit risk of [name of issuer].○The Notes are debt obligations of [name of issuer]. If [name of issuer] is unable to fulfil its obligations under the Notes, you may lose all your principal investment. [State the risks that an investor would face in trying to exit the product. For example, limitations on redemption or factors that may delay the payment of redemption proceeds.] Example:●The Notes are not listed and have limited liquidity.○The Notes are not listed on any exchange and have limited secondary market. You should be prepared to have your principal investment locked in for X years. If you exit from your investment before maturity, you may receive an amount which is substantially less than your principal. [State product structure‑related risks which may result in adverse consequences, including capped upside potential, unfavourable pricing if redeemed before maturity and potential legal risks.] Example:●The issuer is established overseas.○If the issuer becomes insolvent or is the subject of a winding‑up or liquidation order or similar proceedings, the insolvency laws in the country in which it is incorporated would apply. The process of making a claim under the foreign law may be complex and time consuming. ●The underlying securities are held overseas.○There may be difficulties realising the underlying securities which are held overseas. Even if the underlying securities are realised, the foreign law may not recognise that the payments to you should be made before other claimants and creditors. ●If the issuer has to redeem the Notes early, due to taxation and other reasons, you may receive less than your principal investment. WHAT ARE THE FEES AND CHARGES OF THIS INVESTMENT? [State all fees and charges paid or payable to distributors and product providers. If product providers do not charge a fee, describe briefly how product providers will profit from the sale of the Notes. Indicate if the fees are payable once‑off or on a recurring basis. If fees may later be increased or new fees introduced, such as fees related to the unwinding of investments, state so here.]Refer to the “[Relevant Section]” of the Prospectus for further information on fees and charges. Example:●The issuer pays each distributor a commission of 3% of the total amount sold by each distributor. ●While you do not pay any fee to the issuer, the arranger and its related parties make a profit through the structuring of the Notes. This profit is factored into the risk and return of the Notes. HOW OFTEN ARE VALUATIONS AVAILABLE? [State how often and where valuations are published. For example, provide a website address or the name of local newspapers where the valuation is published.]Refer to the “[Relevant Section]” of the Prospectus for further information on valuation and exiting from the product. HOW CAN YOU EXIT FROM THIS INVESTMENT AND WHAT ARE THE RISKS AND COSTS IN DOING SO? [State the length of the cancellation period, if any, and describe how investors can exit from the investment if they change their mind within the cancellation period and the relevant costs. If there is no cancellation period, state so clearly. Subsequent to the cancellation period, describe how investors can exit from the investment and the relevant costs involved.] HOW DO YOU CONTACT US? [State the contact details of the issuers or distributors whom investors can contact if they have enquiries. Include a website address and email address, if appropriate.] Part 2PRODUCT HIGHLIGHTS SHEET1. For the purposes of regulation 7(4), each of the following product highlights sheets relating to an offer of relevant securities or securities‑based derivatives contracts does not provide a fair and balanced view of the relevant securities or securities‑based derivatives contracts:
a product highlights sheet that contains a statement on any return of the principal sum invested in the relevant securities or securities‑based derivatives contracts, or benefit of holding the relevant securities or securities‑based derivatives contracts, but —
does not provide an unbiased description of risks associated with the relevant securities or securities‑based derivatives contracts; or
does not give a proportionate level of prominence to any warning, disclaimer or qualification which is disclosed in relation to that statement;
a product highlights sheet relating to relevant securities or securities‑based derivatives contracts that are structured with the objective of returning the full principal sum invested in the relevant securities or securities‑based derivatives contracts to a holder of those relevant securities or securities‑based derivatives contracts upon the maturity of those relevant securities or securities‑based derivatives contracts, but where the return of the full principal sum invested in the relevant securities or securities‑based derivatives contracts at maturity is not unconditionally guaranteed, and the product highlights sheet does not contain a statement which clearly highlights the fact that the return of the full principal sum invested in the relevant securities or securities‑based derivatives contracts at maturity is not unconditionally guaranteed;
a product highlights sheet that contains a representation that the return of all or a part of the principal sum invested in the relevant securities or securities‑based derivatives contracts, or the rate of return on the relevant securities or securities‑based derivatives contracts is guaranteed, but —
does not state the name of the guarantor; or
does not contain a statement that clearly highlights that while there is a guarantor who guarantees the return of all or a part of the principal sum invested in the relevant securities or securities‑based derivatives contracts, or the rate of return on the relevant securities or securities‑based derivatives contracts, there is no assurance that the guarantor will be able to fulfil its obligations under such guarantee;
a product highlights sheet that contains historical information on the relevant securities or securities‑based derivatives contracts, but does not contain a statement that the information presented is historical information and that the past performance of the relevant securities or securities‑based derivatives contracts is not indicative of its future performance;
a product highlights sheet that gives the impression that an investor can profit from investing in the relevant securities or securities‑based derivatives contracts without any risk;
a product highlights sheet that suggests that the nature of the relevant securities or securities‑based derivatives contracts is, or is comparable to, a deposit;
a product highlights sheet relating to relevant securities or securities‑based derivatives contracts of which the return of the principal sum invested in the relevant securities or securities‑based derivatives contracts or the rate of return on the relevant securities or securities‑based derivatives contracts is not guaranteed, but suggests that any of the following risks is low or nil:
the risk of the holder of the relevant securities or securities‑based derivatives contracts losing the holder’s principal sum invested;
the risk of the holder of relevant securities or securities‑based derivatives contracts not achieving the stated, targeted or expected rate of return of the holder’s principal sum invested.
2. For the purposes of regulation 7(5), each of the following product highlights sheets relating to an offer of relevant securities or securities‑based derivatives contracts is false or misleading:
a product highlights sheet that omits any material information on the relevant securities or securities‑based derivatives contracts and as a result of which, the product highlights sheet or any part of the product highlights sheet is false or misleading;
a product highlights sheet that contains a false or misleading statement on the offer of relevant securities or securities‑based derivatives contracts;
a product highlights sheet that contains information that cannot be justified based on the facts known to the person making the offer of the relevant securities or securities‑based derivatives contracts;
a product highlights sheet that contains any information, in text or otherwise, that is inaccurate or inconsistent with the nature or risks of the relevant securities or securities‑based derivatives contracts;
a product highlights sheet that contains any exaggerated statement, which is calculated to exploit an individual’s lack of experience and knowledge;
a product highlights sheet that contains information which is inconsistent with any information provided by the offer or of the relevant securities or securities‑based derivatives contracts to the person publishing or disseminating the product highlights sheet;
a product highlights sheet that contains or refers to any graph, chart, formula or other device, and represents directly or indirectly, that —
the graph, chart, formula or device (as the case may be) can, in and of itself, be used to determine which relevant securities or securities‑based derivatives contracts to buy or sell, or when to buy or sell such relevant securities or securities‑based derivatives contracts; or
the graph, chart, formula or device (as the case may be) will assist any person in deciding which relevant securities or securities‑based derivatives contracts to buy or sell, or when to buy or sell such relevant securities or securities‑based derivatives contracts,but does not prominently disclose the limitations, and difficulties in respect of the use, of the graph, chart, formula or device, as the case may be;
a product highlights sheet that contains any statement to the effect that any report, analysis or other service will be furnished free or without charge, and such report, analysis or service is not in fact or will not in fact be furnished in its entirety and without any condition or obligation.